Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4793059
Max Phase: Preclinical
Molecular Formula: C46H55FN8O10S
Molecular Weight: 931.06
Molecule Type: Unknown
Associated Items:
ID: ALA4793059
Max Phase: Preclinical
Molecular Formula: C46H55FN8O10S
Molecular Weight: 931.06
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)C)c(OCCCCC(=O)NCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)c1
Standard InChI: InChI=1S/C46H55FN8O10S/c1-25-37(66-24-51-25)26-11-12-27(22-50-39(59)32-21-28(56)23-54(32)43(63)38(45(2,3)4)53-44(64)46(47)15-16-46)33(20-26)65-19-6-5-10-34(57)49-18-17-48-30-9-7-8-29-36(30)42(62)55(41(29)61)31-13-14-35(58)52-40(31)60/h7-9,11-12,20,24,28,31-32,38,48,56H,5-6,10,13-19,21-23H2,1-4H3,(H,49,57)(H,50,59)(H,53,64)(H,52,58,60)/t28-,31?,32+,38-/m1/s1
Standard InChI Key: FDXZMKIGERUKNS-LDYGXKOKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 931.06 | Molecular Weight (Monoisotopic): 930.3746 | AlogP: 2.91 | #Rotatable Bonds: 18 |
Polar Surface Area: 245.54 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.94 | CX Basic pKa: 2.61 | CX LogP: 1.11 | CX LogD: 1.11 |
Aromatic Rings: 3 | Heavy Atoms: 66 | QED Weighted: 0.08 | Np Likeness Score: -0.55 |
1. Girardini M,Maniaci C,Hughes SJ,Testa A,Ciulli A. (2019) Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs., 27 (12.0): [PMID:30826187] [10.1016/j.bmc.2019.02.048] |
Source(1):